Company profile
Unicycive Therapeutics, Inc.
Pipeline2 assets
- Oxylanthanum CarbonateOLC / Renazorb / Phosphate / Small molecule / NephrologyHyperphosphatemia in chronic kidney disease (CKD) on dialysisNDAResubmittedUnited States
- UNI-494UNI-494 / KATP channel / Nitric oxide (nicorandil prodrug) / Small molecule / NephrologyAcute Kidney Injury (AKI)Phase 1CompletedUnited KingdomUnited StatesPrevention of Delayed Graft Function (DGF) in kidney transplant patientsPhase 1ActiveUnited States